{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:10:46Z","timestamp":1782187846006,"version":"3.54.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10067-020-05364-1","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T08:03:41Z","timestamp":1598688221000},"page":"2071-2073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["IgA vasculitis during secukinumab therapy"],"prefix":"10.1007","volume":"40","author":[{"given":"Dijana","family":"Perkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Simac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-1919","authenticated-orcid":false,"given":"Josip","family":"Katic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"issue":"1","key":"5364_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/2040622317738910","volume":"9","author":"J Frieder","year":"2018","unstructured":"Frieder J, Kivelevitch D, Menter A (2018) Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis. Ther Adv Chronic Dis 9(1):5\u201321. https:\/\/doi.org\/10.1177\/2040622317738910","journal-title":"Ther Adv Chronic Dis"},{"key":"5364_CR2","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.2147\/DDDT.S105263","volume":"10","author":"MI Koenders","year":"2016","unstructured":"Koenders MI, van den Berg WB (2016) Secukinumab for rheumatology: development and its potential place in therapy. Drug Des Devel Ther 10:2069\u20132080. https:\/\/doi.org\/10.2147\/DDDT.S105263","journal-title":"Drug Des Devel Ther"},{"key":"5364_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957\u2013970. https:\/\/doi.org\/10.1056\/NEJMra1505557","journal-title":"N Engl J Med"},{"key":"5364_CR4","unstructured":"Armstrong AW, Papp K, Kircik L. Secukinumab (2016) Review of clinical evidence from the pivotal studies ERASURE, FIXTURE, and CLEAR. J Clin Aesthet Dermatol9(6 Suppl 1):S7-S12"},{"issue":"6 Suppl 1","key":"5364_CR5","first-page":"S12","volume":"9","author":"AW Armstrong","year":"2016","unstructured":"Armstrong AW, Vender R, Kircik L (2016) Secukinumab in the treatment of palmoplantar, nail, scalp, and pustular psoriasis. J Clin Aesthet Dermatol 9(6 Suppl 1):S12\u2013S16","journal-title":"J Clin Aesthet Dermatol"},{"key":"5364_CR6","doi-asserted-by":"publisher","unstructured":"Villani A, De Fata SG, Nappa P, Megna M, Fabbrocini G, Napolitano M (2019) Cutaneous leucocytoclastic vasculitis during secukinumab treatment. G Ital Dermatol Venereol. https:\/\/doi.org\/10.23736\/S0392-0488.18.06203-X","DOI":"10.23736\/S0392-0488.18.06203-X"},{"key":"5364_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.mayocp.2012.04.011","volume":"87","author":"O Sokumbi","year":"2012","unstructured":"Sokumbi O, Wetter DA, Makol A, Warrington KJ (2012) Vasculitis associated with tumor necrosis factor alpha inhibitors. Mayo Clin Proc 87:739\u2013745. https:\/\/doi.org\/10.1016\/j.mayocp.2012.04.011","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"5364_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","volume":"73","author":"B Saint Marcoux","year":"2006","unstructured":"Saint Marcoux B, De Bandt M, CRI (Club Rhumatismes et Inflammation) (2006) Vasculitides induced by TNF\u03b1 antagonists: a study in 39 patients in France. Joint Bone Spine 73(6):710\u2013713. https:\/\/doi.org\/10.1016\/j.jbspin.2006.02.010","journal-title":"Joint Bone Spine"},{"key":"5364_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/742535","volume":"742535","author":"X Jue","year":"2015","unstructured":"Jue X, Yan L, Lei W, Guoxiang R et al (2015) Expansion of circulating T follicular helper cells in children with acute Henoch-Sch\u00f6nlein purpura, Hindawi Publishing Corporation. J Immunol Res 742535:1\u20139. https:\/\/doi.org\/10.1155\/2015\/742535","journal-title":"J Immunol Res"},{"issue":"10136","key":"5364_CR10","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391(10136):2273\u20132284","journal-title":"Lancet"},{"issue":"8","key":"5364_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/sj.gene.6363716","volume":"1","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC (2000) IL-TIF\/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 1(8):488\u2013494. https:\/\/doi.org\/10.1038\/sj.gene.6363716","journal-title":"Genes Immun"},{"issue":"6808","key":"5364_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/35040504","volume":"408","author":"J Parrish-Novak","year":"2000","unstructured":"Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA et al (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408(6808):57\u201363. https:\/\/doi.org\/10.1038\/35040504","journal-title":"Nature"},{"issue":"9","key":"5364_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T et al (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8(9):967\u2013974. https:\/\/doi.org\/10.1038\/ni1488","journal-title":"Nat Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05364-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T23:40:10Z","timestamp":1630194010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05364-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5364"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05364-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,29]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}